Page 20 - Gsk Plc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Musk s Neuralink valued at about $5 billion despite long road to market: Reuters

Musk s Neuralink valued at about $5 billion despite long road to market: Reuters
cnbc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnbc.com Daily Mail and Mail on Sunday newspapers.

Galvani bioelectronicsAsim desaiVarun sridharElon muskUs national institutes of healthAlphabet inc verily life sciencesDrug administrationAlphabet incVerily lifeUnited statesGsk plcBreaking news technologyHealth care industryBreaking news marketsBusiness news

FDA approves Pfizer RSV vaccine for older adults

The approval of a vaccine by Pfizer targeting RSV comes just weeks after the Food and Drug Administration cleared a similar shot made by GSK.

Drug administration onCenters for diseaseDrug administrationDisease controlSocial issuesBreaking news businessDisease outbreaksBiotech and pharmaceuticalsUs economyHealth care industryPfizer incGsk plcRespiratory syncytial virusBusiness news

RSV vaccine: FDA advisors recommend Pfizer s shot for infants

The FDA is slated to make a decision on whether to approve Pfizer's shot in August before respiratory syncytial virus season in the fall.

United statesYugenia hong nguyenPaul offitWilliam gruberPfizer incRespiratory syncytial virusCenters for disease control and preventionGsk plcHealth care industryBiotech and pharmaceuticalsSocial issuesBreaking news businessBusiness news

Cramer s Lightning Round:

"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

Frank slootmanDame emma walmsleyEli lillyJensen huangEnterprise products partnersProducts partnersCoinbase globalTriple flag precious metalFlag precious metalsJim cramerInvestment strategyStock marketsChewy incEnterprise products partners lpMagellan midstream partners lpOneok inc

Global Gastroesophageal Reflux Disease Therapeutics Market

Dublin, May 16, 2023 (GLOBE NEWSWIRE) The "Gastroesophageal Reflux Disease Therapeutics Market Size, Share & Trends Analysis Report By Drug Type.

United statesTakeda pharmaceutical companyEisai co ltdCompany categorizationKey emerging companiesSebela pharmaceuticalsPhathom pharmaceuticalsRegional networkJohnson services incPhathom pharmaceuticals incCamber pharmaceuticals incDrug administrationIronwood pharmaceuticals incPublic companiesGsk plcSfj pharmaceuticals